Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
1992-1-22
pubmed:abstractText
Activation of the ras oncogene was investigated in esophageal tumors induced by methylbenzylnitrosamine (MBN) in the Sprague-Dawley rat. DNA was extracted from grossly visible carcinogen-induced tumors. H-ras and K-ras gene sequences were then amplified by the polymerase chain reaction. Point mutations in the ras genes were then identified by selective hybridization to allele-specific oligonucleotide probes. A guanine to adenine transition at the 35th nucleotide in the H-ras coding sequence (GGA to GAA in the 12 codon) was observed in 67% (10 of 15) of the papillomas examined. This mutation codes for glutamate instead of glycine as the 12th amino acid of the ras p21 protein. No other H-ras or K-ras mutations were observed. To determine the distribution of this H-ras mutation in esophageal tissues, histological sections of MBN-treated esophagi were stained with a monoclonal antibody (E184) which selectively recognizes the mutated ras p-21 with glutamate substituted for glycine as the 12th amino acid. Expression of the mutant ras p21 protein was observed in 20% of the squamous papillomas, 13.6% of hyperplastic lesions and 10% of dysplastic lesions. Thus, activation of the H-ras oncogene as a result of guanine to adenine point mutation is a frequent event in esophageal tumors induced by MBN, occurring in 67% of squamous papillomas, but expression of the corresponding mutant ras p21 protein is observed in a much smaller proportion of the tumors in this animal model.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0143-3334
pubmed:author
pubmed:issnType
Print
pubmed:volume
12
pubmed:geneSymbol
H-ras, ras
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2373-7
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:1747941-Adenine, pubmed-meshheading:1747941-Animals, pubmed-meshheading:1747941-Base Sequence, pubmed-meshheading:1747941-Carcinogens, pubmed-meshheading:1747941-Codon, pubmed-meshheading:1747941-Dimethylnitrosamine, pubmed-meshheading:1747941-Esophageal Neoplasms, pubmed-meshheading:1747941-Esophagus, pubmed-meshheading:1747941-Gene Expression Regulation, Neoplastic, pubmed-meshheading:1747941-Genes, ras, pubmed-meshheading:1747941-Guanine, pubmed-meshheading:1747941-Immunohistochemistry, pubmed-meshheading:1747941-Male, pubmed-meshheading:1747941-Molecular Sequence Data, pubmed-meshheading:1747941-Mutation, pubmed-meshheading:1747941-Oncogene Protein p21(ras), pubmed-meshheading:1747941-Papilloma, pubmed-meshheading:1747941-Rats, pubmed-meshheading:1747941-Rats, Inbred Strains
pubmed:year
1991
pubmed:articleTitle
Incidence of Harvey ras oncogene point mutations and their expression in methylbenzylnitrosamine-induced esophageal tumorigenesis.
pubmed:affiliation
Department of Medicine, Northwestern University Medical School, Chicago, IL.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't